Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead
Go back to Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead| AGENUS (NASDAQ: AGEN) | Delayed: 8.09 +0.60 (8.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.49 | 52 Week High | $7.49 | |||
| Open | $7.58 | 52 Week Low | $2.61 | |||
| Day High | $8.35 | P/E | N/A | |||
| Day Low | $7.58 | EPS | $-1.10 | |||
| Volume | 1,517,505 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 146.12 +2.68 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.44 | 52 Week High | $108.63 | |||
| Open | $144.52 | 52 Week Low | $71.39 | |||
| Day High | $147.91 | P/E | 80.73 | |||
| Day Low | $143.50 | EPS | $1.81 | |||
| Volume | 5,384,399 | |||||
